Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

5.46
Delayed Data
As of 4:00pm ET
 +0.09 / +1.68%
Today’s Change
3.50
Today|||52-Week Range
6.47
+18.70%
Year-to-Date
No recent news for Chimerix Inc.

Today’s Trading

Previous close5.37
Today’s open5.34
Day’s range5.21 - 5.46
Volume452,836
Average volume (3 months)498,943
Market cap$248.7M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-48.33%
Earnings growth (this year)+35.19%
Earnings growth (next 5 years)--
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales36.49
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.04-0.61%
IDRAIdera Pharmaceutical...-0.06-3.47%
MNKDMannKind Corp+0.01+2.61%
TTPHTetraphase Pharmaceu...+0.13+2.50%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$10.8M
Annual profit (last year)-$117.4M
Net profit margin-1,090.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs